<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Pharmaceutical-Crystallization on Bioecon</title><link>https://en.bioecon.ru/technologies/pharmaceutical-crystallization/</link><description>Recent content in Pharmaceutical-Crystallization on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sun, 26 Jul 2026 12:35:40 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/pharmaceutical-crystallization/index.xml" rel="self" type="application/rss+xml"/><item><title>Crystallization equipment for pharmaceutical APIs</title><link>https://en.bioecon.ru/technology/crystallization-equipment-pharma-api/</link><pubDate>Sat, 25 Jul 2026 20:55:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/crystallization-equipment-pharma-api/</guid><description>The stirred, draft-tube-baffled, melt and continuous crystallizers — plus the inline FBRM/PVM probes that close the loop on them — that turn a purified API molecule into a defined polymorph with a target particle-size distribution, the unit operation on which bioavailability, purity and downstream filterability all depend.</description></item></channel></rss>